Heath Lukatch

Chairman

Heath Lukatch has extensive healthcare venture investing experience. He joined and opened Novo Ventures’ San Francisco office in 2006, was a founding partner of SightLine Partners, and was Managing Director and Head of Biotechnology Venture Investments at Piper Jaffray Ventures. Heath has invested in multiple medical device and biotechnology companies. In addition to Inogen, Heath also serves as a Director at Synosis and NeuroTherapeutics.

Prior to his involvement in venture capital, Heath worked as a strategy consultant with McKinsey & Company, serving a range of large and small healthcare clients. Before joining McKinsey, Heath was founder and CEO of AutoMate Scientific, a San Francisco-based biotechnology instrumentation manufacturer and marketer. In addition, Heath was a bench scientist at Chiron, Cetus and Roche Bioscience in the areas of molecular biology, protein chemistry and electrophysiology, respectively.

Heath earned his Ph.D. in Neuroscience with emphasis in Pharmacology from Stanford University and his undergraduate degree with high honors in Biochemistry from the University of California at Berkeley.

Raymond Huggenberger

CEO

Raymond Huggenberger, former COO of Sunrise Medical, brings over 20 years of deep operating experience to Inogen. Well known in the field of durable medical equipment (DME), Mr. Huggenberger will drive the expansion of Inogen's oxygen business.

Raymond comes to Inogen with a track record of success as a Senior Executive with a global focus. He spent the last 10 years with SUNRISE MEDICAL Inc., a global manufacturer and distributor of durable medical equipment, where he held multiple senior management positions, highlighted by his service as President & Chief Operating Officer from 2002 to 2004. During his tenure with Sunrise, he succeeded in returning the company to positive revenue growth, and implemented "lean principles" to greatly improve the company's cost structure. During his career in the DME industry, Raymond has held positions in Marketing, Sales, Product Development and General Management.

Raymond was instrumental in several acquisitions and divestitures and was part of the core team to take Sunrise private in December 2000. He was also part of the core team who successfully spun off the German TA Healthcare division, which was sold to Warburg Pincus in January 1998.

Raymond is a graduate from AKAD University in Rendsburg, Germany in Marketing and from INSEAD, Fontainebleau, France in Advanced Marketing Strategies.

Steve Cooper

Director

Steve Cooper is a highly accomplished, successful entrepreneur and executive with over 35 years of experience leading companies in the semiconductor, semiconductor equipment, software and medical device industries.

Steve began at Intel in 1973, where he held various engineering and management positions, including Engineering Manager and Wafer Fabrication Manager. From 1980 to 1987 Steve held various positions, including President and COO, with Silicon Systems, Inc., a manufacturer of analog/digital semiconductors; from 1987-1990 he served as President and CEO of Bipolar Integrated Technology, a manufacturer of bipolar semiconductors. In 1993 he was hired to turnaround Etec Systems, which he took public in 1995 and sold to Applied Materials in March 2000 in a transaction valued at approximately $2.5 billion. In 2001 Steve provided seed financing to start Inogen.

Steve served as Inogen’s Chairman from founding until 2008 and today continues as a Director. In 2003 Steve founded Skyler Technology, Inc. a developer of enterprise software for the financial services industry and served as its Chairman and CEO until it moved to London in January 2010. In 2010 Steve started High Tech CEO Advisor to focus on mentoring CEO’s of early stage companies. Steve holds a BSEE from University of California, Santa Barbara where he is a Trustee, a member of the College of Engineering Dean’s Cabinet and a member of the Advisory Board for the Technology Management Program. Currently Steve is a member of the boards of Inogen, Aurrion, Active Life Scientific and Built on Logic.

William J. Link, Ph.D.

Director

Bill Link has a proven record of building and operating large, successful medical product companies; his operating experience spans more than 23 years in general management in the healthcare industry.

One of Bill's most significant operational successes was as founder, chairman and CEO of Chiron Vision, an ophthalmic surgical products company which was sold to Bausch and Lomb in 1997 for $310 million.

Prior to entering the healthcare industry, Bill was an assistant professor in the Department of Surgery at the Indiana University School of Medicine.

Bill is currently Managing Director of Versant Ventures, which he co-founded. In addition to Inogen, Bill is a director of Cameron Health (private), AcuFocus (private) and Glaukos (private). Bill received his bachelor's, master's and doctorate degrees in mechanical engineering from Purdue University.

Charles Larson

Director

As a co-founder and Managing Partner of Accuitive Medical Ventures, Charlie brings over 25 years of operating experience, as well as expansive technical understanding and experience in the medical device industry. Charlie was a co-founder of Novoste Corporation where his efforts as a director and executive were critical to its ultimate success.

Charlie co-founded The Innovation Factory and serves as its Vice Chairman. Through his role at The Innovation Factory, he is co-founder of AcuFocus, LipoSonix, Cerebral Vascular Applications, NeoVista and NeuroNetics. He is the Chairman and Chief Technical Officer of OsteoLign and AqueSys and serves as the Chief Technical Officer of Cellutions. Charlie holds over 20 issued U.S. patents on medical devices. Prior to joining Novoste, Charlie held positions with Cordis Corporation and Parke-Davis in various engineering and project management roles. Charlie received a B.S. in Mechanical Engineering from the New Jersey Institute of Technology

Tim Petersen

Director

Tim Petersen leverages his broad business experience creating, growing, and financing entrepreneurial firms to target promising capital-efficient investment opportunities. In recent years he has particularly focused on investments in companies that are changing the way healthcare is delivered. Tim led Arboretum's investment in HealthMedia (acquired by Johnson & Johnson) and Accuri Cytometers (acquired by Becton, Dickinson and Company) and served on the Board of Directors of each company prior to exit. He also led Arboretum's investments in Advanced ICU Care, Inogen, MyHealthDIRECT, and CerviLenz, and presently serves as a director of these companies. Tim is responsible for Arboretum's financial and fund management activities and is a member of the Investment Committee. He has been a venture capital investor for the past twelve years.

Prior to joining Arboretum in 2002, Tim was the Managing Director of the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan, leading the creation and rapid growth of the Institute's programs. He also directed the Wolverine Venture Fund (WVF), the Institute's venture capital fund focusing on early-stage life science and technology investments. Previously, Tim spent nine years at the economic consulting firm Industrial Economics, Inc., becoming a member of the firm's senior staff in 1991. Earlier in his career, Tim was also a manager in the investment banking practice at Plante & Moran.

Tim is involved in a number of community efforts focused on entrepreneurship and frequently lectures at local universities on venture capital. He is currently the Alumni Fund Manager for the Wolverine Venture Fund and is a member of the Board of Directors of the Michigan Venture Capital Association, where he is slated to become chairman in late 2011.

Tim earned a BA in Economics from Williams College, where he was captain of the men's tennis team. He also holds an MS in Economics from the University of Wisconsin-Madison, and an MBA from the Ross School of Business at the University of Michigan.